EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
Edwards Lifesciences Corp (EW) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $230.80M | $210.20M | $153.20M | $165.30M | $251.40M | $314.50M | $373.80M | $472.70M | $1.02B | $549.70M | $704.40M | $1.00B | $926.80M | $1.18B | $1.05B | $1.73B | $1.22B | $895.80M | $542.30M | $1.60B |
| Capital expenditures | $59.40M | $62.50M | $78.00M | $64.00M | $63.00M | $90.60M | $127.70M | $110.10M | $93.70M | $106.50M | $217.40M | $175.50M | $241.70M | $278.40M | $407.30M | $329.80M | $264.80M | $266.30M | $252.40M | $260.20M |
| Depreciation | $56.80M | $54.80M | $55.60M | $58.70M | $56.50M | $58.00M | $57.30M | $68.70M | $68.60M | $65.80M | $71.20M | $81.90M | $77.40M | $89.30M | $107.20M | $134.80M | $139.60M | $144.90M | $155.20M | — |
| Stock-based comp | $26.60M | $27.70M | $28.70M | $28.30M | $29.30M | $35.00M | $42.10M | $47.40M | $48.30M | $49.90M | $56.90M | $61.60M | $71.00M | $81.30M | $92.60M | $109.30M | $126.80M | $139.40M | $162.30M | $158.10M |
| Free cash flow | $171.40M | $147.70M | $75.20M | $101.30M | $188.40M | $223.90M | $246.10M | $362.60M | $928.60M | $443.20M | $487.00M | $825.20M | $685.10M | $901.00M | $647.00M | $1.40B | $953.40M | $629.50M | $289.90M | $1.33B |
| Investing cash flow | $-35.70M | $-144.50M | $58.80M | $40.10M | $-61.50M | $-412.80M | $-90.50M | $-412.70M | $-633.00M | $-316.10M | $-211.70M | $-647.20M | $76.70M | $-595.80M | $-531.10M | $-1.72B | $252.30M | $173.80M | $2.31B | — |
| Financing cash flow | $-193.60M | $-108.10M | $-134.10M | $-91.80M | $-103.90M | $-135.20M | $-155.60M | $34.90M | $-153.00M | $-158.60M | $-268.50M | $-473.20M | $-1.10B | $-115.60M | $-486.90M | $-356.30M | $-1.58B | $-711.00M | $-983.00M | — |
| Dividends paid | — | — | $206.30M | $129.30M | $254.40M | $526.10M | $407.00M | $1.30B | $226.30M | $31.40M | $253.50M | $0.00 | $688.00M | $18.90M | $140.50M | $158.60M | $146.40M | $169.90M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $62.00M | $-224.90M | $139.70M | $109.50M | $233.40M | $64.60M | $211.70M | $-111.80M | $-104.20M | $468.00M | $36.30M | $-346.70M | $-114.00M | — | — | — |